Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ozkiliç

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Nuclear Medicine|August 31, 1999
False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastomaZ Ozcan, G Erenel, S Aksoylar, et al.
Nuclear Medicine Communications|June 14, 2001
Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumoursZ Ozcan, Z Burak, R Erinç, et al.
Nuclear Medicine Communications|November 26, 1999
The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphyZ Burak, D A Yüksel, N Cetingül, et al.
Nuclear Medicine Communications|February 9, 1999
Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphyZ Ozcan, Z Burak, K Kumanlioğlu, et al.
Nuclear Medicine Communications|August 1, 1994
Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonographyZ Burak, M Argon, A Memiş, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 7, 2010
Long-term evaluation of chromosomal breakages after radioisotope synovectomy for treatment of target joints in patients with haemophiliaK Kavakli, O Cogulu, S Aydogdu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Nuclear Medicine|August 31, 1999
False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastomaZ Ozcan, G Erenel, S Aksoylar, et al.
Nuclear Medicine Communications|June 14, 2001
Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumoursZ Ozcan, Z Burak, R Erinç, et al.
Nuclear Medicine Communications|November 26, 1999
The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphyZ Burak, D A Yüksel, N Cetingül, et al.
Nuclear Medicine Communications|February 9, 1999
Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphyZ Ozcan, Z Burak, K Kumanlioğlu, et al.
Nuclear Medicine Communications|August 1, 1994
Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonographyZ Burak, M Argon, A Memiş, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 7, 2010
Long-term evaluation of chromosomal breakages after radioisotope synovectomy for treatment of target joints in patients with haemophiliaK Kavakli, O Cogulu, S Aydogdu, et al.
Pageof 1